Management of Low-Grade Appendiceal Neoplasm
For patients with low-grade appendiceal neoplasm discovered on histology after appendectomy, management should be based on tumor size, location, and histological features, with right hemicolectomy indicated for tumors ≥2 cm or those with high-risk features. 1
Decision Algorithm Based on Tumor Size and Features
For Well-Differentiated Tumors <2 cm:
- Simple appendectomy is sufficient for tumors <1 cm confined to the appendix with no adverse features, as this is likely curative 1
- No extended follow-up is necessary for completely resected lesions <1 cm 1
- Further resection (right hemicolectomy) should be considered if the tumor:
For Tumors ≥2 cm:
- Right hemicolectomy is indicated, even without obvious malignant features 1
- This recommendation is based on higher risk of lymph node metastases and locoregional spread 1
For Goblet Cell Appendiceal Tumors:
- Right hemicolectomy is always required regardless of size due to their more aggressive behavior 1
- These tumors should be managed according to colon cancer protocols rather than typical neuroendocrine tumor protocols 1, 2
- In women, consider bilateral oophorectomy due to increased risk of pelvic peritoneal metastases 1
Staging and Additional Workup
For patients with incomplete resection or tumors ≥2 cm:
For low-grade appendiceal mucinous neoplasms (LAMN):
Surveillance Recommendations
For tumors <2 cm with complete resection and no adverse features:
For larger tumors or those with adverse features:
Important Considerations and Pitfalls
- Avoid unnecessary right hemicolectomy for small (<1 cm) well-differentiated tumors at the tip of the appendix without adverse features 1, 4
- Be aware that even small tumors with certain histological features (invasion, location at base) may require more aggressive management 1
- For LAMN, a detailed pathological assessment is crucial as T stage, appendix perforation, and presence of acellular mucin on the serosa are important prognostic factors 3, 5
- Referral to centers with experience in peritoneal surface malignancies should be considered for complex cases, especially those with evidence of peritoneal spread 6